DarioHealth
DRIO
17 hedge funds and large institutions have $8.37M invested in DarioHealth in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
24.01% less ownership
Funds ownership: 34.89% → 10.88% (-24%)
26% less funds holding
Funds holding: 23 → 17 (-6)
39% less capital invested
Capital invested by funds: $13.6M → $8.37M (-$5.26M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$908K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$410K |
| 3 |
BlackRock
New York
|
+$215K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$40.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$977K |
| 2 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$567K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$109K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.62K |
| 5 |
Morgan Stanley
New York
|
-$1.06K |
DRIO Hedge Fund Activity: Q4 2025 in Review
17 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2025, worth a combined $8.37M — down 39% from $13.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DRIO and 2 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $908K. The largest seller was Phoenix Financial, exiting entirely with an estimated $977K sold.
- 17 institutional investors held DarioHealth (DRIO) as of Q4 2025, down from 23 in Q3 2025.
- Funds reported $8.37M of DarioHealth stock for Q4 2025, down 39% quarter-over-quarter.
- 2 funds opened new DarioHealth positions in Q4 2025 and 7 closed out, a net change of -5 holders.
- The largest DarioHealth buyer in Q4 2025 was Vanguard Group, an estimated $908K added.
- The largest DarioHealth seller in Q4 2025 was Phoenix Financial, an estimated $977K sold.
Based on aggregated 13F filings for Q4 2025.